Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2015 Apr 23;5(9):829–838. doi: 10.1002/alr.21543

Table 2.

Prevalence of patient-reported medication use for subjects with comorbid anxiety

Patient-reported medication use: N(%)
None 1 (3%)
Benzodiazepines 12 (40%)
Tricyclic anti-depressants 1 (3%)
Selective serotonin reuptake inhibitors (SSRIs) 7 (23%)
Serotonin-norepinephrine reuptake inhibitors (SNRIs) 1 (3%)
Psychotropic medications 3 (10%)
Dual modality therapy 4 (13%)
Marijuana 1 (3%)